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Engineering Melanoma Progression in a Humanized
Environment In Vivo
Gregor Kiowski1,4, Thomas Biedermann2,4, Daniel S. Widmer3, Gianluca Civenni1, Charlotte Burger1,
Reinhard Dummer3, Lukas Sommer1 and Ernst Reichmann2
To overcome the lack of effective therapeutics for aggressive melanoma, new research models closely
resembling the human disease are required. Here we report the development of a fully orthotopic, humanized
in vivo model for melanoma, faithfully recapitulating human disease initiation and progression. To this end,
human melanoma cells were seeded into engineered human dermo–epidermal skin substitutes. Transplantation
onto the back of immunocompromised rats consistently resulted in the development of melanoma, displaying
the hallmarks of their parental tumors. Importantly, all initial steps of disease progression were recapitulated,
including the incorporation of the tumor cells into their physiological microenvironment, transition of radial to
vertical growth, and establishment of highly vascularized, aggressive tumors with dermal involvement. Because
all cellular components can be individually accessed using this approach, it allows manipulation of the tumor
cells, as well as of the keratinocyte and stromal cell populations. Therefore, in one defined model system, tumor
cell-autonomous and non-autonomous pathways regulating human disease progression can be investigated in
a humanized, clinically relevant context.
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INTRODUCTION
Cutaneous melanoma arising from transformation of mela-
nocytes is the most aggressive form of skin cancer (Gray-
Schopfer et al., 2007). Once systemic malignant disease has
been established, the long-term survival of patients is poor, as
despite immense research efforts only few evidence-based
effective therapeutics have emerged (Dummer et al., 2008;
Kuphal and Bosserhoff, 2009). This poor translation of basic
research to the clinics has led to the understanding that new
research models are needed. In particular, the development
of fully humanized orthotopic systems has been deemed
crucial, because such systems would allow the investigation
of central processes of human melanoma formation in their
original tissue context (Khavari, 2006; Dirks, 2010; Weinberg
et al., 2010). This remains technically challenging, how-
ever, because of the staggered nature of human melanoma
progression. First, neoplastic cells emerge from their
original microenvironment at the dermo–epidermal junction.
Subsequently, the cells establish radial growth by prolifera-
tion within the confines of the epidermis, leaving the
underlying basement membrane intact. Accumulating inva-
sive traits, the cells then switch to a vertical growth pattern by
pushing through the basement membrane into the dermal
compartment (Guerry et al., 1993). Following extensive
dermal growth, hypoxic areas are established within the
tumor, which not only triggers neovascularization but also
enhances tumor cell aggressiveness and survival (Pouysse´gur
et al., 2006; Lee and Herlyn, 2007).
Thus, to model the inherent complexity of human
melanoma, a system is required that allows the exact
recapitulation of all these steps in vivo. Whereas orthotopic
in vitro model systems have emerged using organotypic skin
reconstructs (Hsu et al., 1998; Bechetoille et al., 2000; Eves
et al., 2000; Meier et al., 2000; Berking et al., 2001; Haass
et al., 2005), fully orthotopic, humanized in vivo models are
still missing. Neither subcutaneous injection into immuno-
compromised mice (Quintana et al., 2008, 2010; Schatton
et al., 2008) nor more recent advances, including intradermal
injections into human foreskin grafts (Juhasz et al., 1993;
Boiko et al., 2010) or skin reconstructs using human
devitalized dermal substrate (Chudnovsky et al., 2005),
provide the structural context equivalent to the site of human
tumor formation. On one hand, subcutaneous or intradermal
injections, even into a human skin graft (Juhasz et al., 1993;
Boiko et al., 2010), cannot recapitulate the important early
steps of invasion from the epidermal compartment through
the basement membrane into the dermis. On the other hand,
the use of a devitalized dermal substrate (Chudnovsky et al.,
2005) creates an unfavorable chimeric environment, as the
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graft gets populated with recipient fibroblasts rather than with
human stromal cells (Medalie et al., 1996; Bhowmick et al.,
2004; Khavari, 2006; Gaggioli et al., 2007; Ridky et al.,
2010).
The system described here surpasses the existing models in
combining the structural and microenvironmental prerequi-
sites of a humanized orthotopic model. Furthermore, it
retains the possibility to experimentally influence every cell
type in the system independently. This is achieved using
recently developed human dermo–epidermal skin substitutes
that are grafted onto the back of immunocompromised rats
(Pontiggia et al., 2009; Biedermann et al., 2010). On the basis
of this approach, our model features the initial incorporation
of melanoma cells into their physiological microenviron-
ment, as well as crucial steps of human disease progression,
such as the invasion of tumor cells through the basement
membrane, their interactions with human stroma, tumor
neovascularization, and tumor cell dissemination.
RESULTS
Melanoma development in engineered human skin substitutes
Aiming at the orthotopic positioning of human melanoma
cells into an epidermal stratum basale of human origin, we
took advantage of human dermo–epidermal skin substitutes
(Pontiggia et al., 2009; Biedermann et al., 2010; Figure 1).
These substitutes were engineered from freshly isolated
human keratinocytes (KCs) that were plated onto high-density
type-I collagen hydrogels containing primary human dermal
fibroblasts. In such composites, melanocytes have been
shown to incorporate into their orthotopic location in vitro
(Haass et al., 2005). To assess their incorporation in vivo, we
transplanted dermo–epidermal skin substitutes into full-
thickness wounds on the back of immunocompromised rats
(Pontiggia et al., 2009; Biedermann et al., 2010; Figure 2a),
potentially allowing to create tumors with extensions closely
representing those of patients’ tumors. Using polypropylene
rings to shelter the grafts from the surrounding rat skin
prevented wound healing through recipient-derived cells and
resulted in the maturation of the skin substitutes to a state
macroscopically resembling human skin (Figure 2b). The
epidermal compartment revealed normal stratification (Figure
2c) and a laminin-10 (Lam10)-positive basement membrane
tightly anchoring the cytokeratin-10 (K10)-expressing epider-
mis to the dermal compartment (Figure 2d). Staining of the
skin grafts for the rat-specific endothelial marker CD31
(rCD31) revealed a fully vascularized dermal compartment,
indicating good acceptance of the graft (Figure 2e). The
integrity of the humanized dermal compartment (Figure 2e,
white dotted line), marked by the human fibroblast-specific
antibody CD90 (Thy1) (hCD90), was maintained for at least
12 weeks, the latest time point analyzed. Moreover, Ki67-
positive proliferating cells in the stratum basale, in conjunc-
tion with the expression of the wound-specific cytokeratin 16
(K16), indicated sustained homeostasis of the epidermal
tissue (Figure 2f). Importantly, the addition of human
melanocytes resulted in their recruitment to the stratum
basale (Figure 2g) where they fully differentiated into
dendritic pigment-producing melanocytes (Figure 2h).
Given the functional integration of melanocytes into their
physiological surroundings, we sought to determine the
behavior of human melanoma cells in this experimental
setup (for detailed information about all samples used, see
Supplementary Table S1 online). To this end, we replaced the
melanocyte fraction with human melanoma cells expressing
green fluorescent protein (GFP). Six weeks after transplanta-
tion, multiple large tumors pushing through an otherwise
well-developed epidermis were observed (Figure 2i). Macro-
scopically, these tumors showed partial pigmentation (Figure
2i, black arrowhead) and a prominent vasculature that readily
ruptured upon touching, leading to excessive bleeding
(Figure 2i, white arrowhead). Macroscopic GFP expression
confirmed that the tumors originated from the seeded
melanoma cells (Figure 2j). Histological analyses further
revealed large, densely growing, non-necrotic GFP-positive
tumors, expressing the two commonly used melanoma
markers MelanA and S100 (Figure 2k–n).
Melanocytes
Keratinocytes
Melanoma cells
Fibroblasts
Figure 1. Experimental approach. Scheme illustrating the experimental approach using human organotypic skin substitutes as the basis for a humanized in vivo
melanoma model. The two main components, keratinocytes (KCs) and dermal fibroblasts, are enzymatically isolated from human neonatal foreskin samples.
A two-step approach, during which the isolated KCs are seeded onto high-density type-I collagen hydrogels containing human dermal fibroblasts, allows the
engineering of a human dermo–epidermal skin equivalent suitable for transplantation. Addition of human melanocytes or melanoma cells results in their
orthotopic incorporation into the skin composites.
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Engineering human melanoma progression in vivo
To analyze the steps of melanoma progression, we added
human GFP-expressing primary melanoma cells in the
physiological ratio of melanocytes to KCs into the skin
substitutes. Following tumor development over 42 days
in vivo, the typical stages of melanoma progression were
revealed (Figure 3a–c). At the day of transplantation, the
tumor cells were already uniformly integrated into the thin
epidermis (Figure 3a). Importantly, the in vitro-generated skin
substitute did not reveal any melanoma cells in the dermal
compartment (Figure 3a). This was crucial to our model, as
inclusion of tumor cells into the dermis would have
compromised the experimental setup, in which dermal tumor
growth needs to be established as a part of disease
progression. At 28 days after transplantation, the graft was
fully integrated and epidermal maturation became evident by
the appearance of distinct KC layers (Figure 3b, middle
panel). At this time point, the tumor cells had integrated into
their natural surrounding in the basal layer of the epidermis,
where the presence of melanomas in situ already marked the
onset of radial, lentiginous tumor growth (Figure 3b, right
panel). After 42 days, tumor cell nests had become
vascularized (Figure 3c, arrowheads) and progressed to
invasive tumors disintegrating the epidermis and penetrating
the dermis (Figure 3c, middle and right panel). Histopatho-
logically, the resulting reconstituted tumors showed strong
resemblance to the original patient tumor from which the
cells had been derived (Figure 3d and e). Although the
reconstituted tumor was smaller at the time point analyzed,
both lesions showed a similar nodular growth pattern
featuring lentiginous nests, a similar overall cell morphology,
epithelial spread of single cells (Figure 3d and e, insets 1), and
dermal invasion (Figure 3d and e, insets 2). Strikingly, both
parental and reconstituted tumors substantially interfered
with the epidermal integrity (Figure 3d and e), which
presumably correlated with ulceration, a clinically significant
prognostic feature (Gershenwald et al., 2010). These data
demonstrate that reconstitution of a primary melanoma in a
humanized environment not only recapitulates the onset of
human disease in vivo but also gives rise to tumors
histologically resembling their original human counterparts.
However, although primary melanoma biopsies are rarely
accessible, a plethora of metastasis samples and cell lines are
available for research. Therefore, we explored the potential of
cells derived from human metastasis samples to assume
In vivo reconstituted skin
H/E
Fontana–Masson
In vivo reconstituted melanoma
H/E
MelanA S100
K10 / Lam10
Ki67 / K16hCD90 / rCD31
HMB45 / Lam5
GFP
GFP / DAPI
Figure 2. Transplantation of human skin substitutes containing either
melanocytes or melanoma cells. Transplantation of a human
dermo–epidermal skin substitute (a) drives its maturation within 3 weeks (b).
Bar¼1 cm. Analysis of the resulting skin by (c) hematoxylin and eosin (H/E),
(d) laminin-10 (Lam10) and cytokeratin-10 (K10), (e) hCD90 and rat-specific
endothelial marker CD31 (rCD31), and (f) Ki67 and K16 stainings reveal
typical skin histology and sustained homeostasis. Bars¼50 mm. (g) Addition
of human melanocytes (HMB45) results in their orthotopic incorporation into
the stratum basale contacting the underlying basement membrane (Lam5)
in vivo. (h) This leads to fully differentiated dendritic, pigment-producing
melanocytes (Fontana–Masson). Bars¼ 20 mm. (i and j) Replacing the
melanocytes with green fluorescent protein (GFP)-expressing human
melanoma cells (ID4286) results in ulcerated, bleeding (white arrowhead),
partially pigmented (black arrowhead), GFP-expressing tumors. Bars¼ 1 cm.
(k–n) Analysis reveals a dense lesion uniformly expressing GFP, MelanA,
and S100. Bars¼1mm.
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primary tumor characteristics if exposed to the appropriate
microenvironment. Intriguingly, metastasis-derived melano-
ma cells recapitulated the key events of early disease
progression, indicating a remarkable context-dependent
plasticity (Lipkin, 2008; Roesch et al., 2010). Strikingly, cells
derived from an axillary skin metastasis, not only adopted a
progression pattern similar to transplanted primary melanoma
cells but were also found to recapitulate many histopatholo-
gical characteristics of the primary patient tumor, from which
the metastasis had originated (Figure 4a and b and
Supplementary Figure S1 online). Tumor growth started at
the dermo–epidermal junction, giving rise to tumors mirroring
the original tumor cell morphology, nodular growth pattern,
ulceration, as well as dermal and epidermal invasion (Figure
4a and b, insets 1). Furthermore, 50% of all reconstituted
tumors (6/12) derived from this axillary skin metastasis
sample gave rise to satellite metastases in the skin, similar
to those found in the corresponding primary tumor (Figure 4a
and b, insets 2 and Supplementary Figure S1 online, inset 2).
Intriguingly, these features were recapitulated irrespective of
whether the cells had been maintained as xenografts in mice
(Figure 4b) or as sphere cultures in vitro (Supplementary
Figure S1 online). Moreover, analysis of the most commonly
used clinical melanoma markers S100, MelanA, HMB45, as
well as the clinically relevant prognostic factor Ki67 (Balch
et al., 2009), further confirmed the close resemblance
between reconstituted tumors and their patient-matched
counterparts (Supplementary Figure S2 online). This showed
that even melanoma cells isolated from metastases harbor the
potential to recapitulate original primary tumor growth if
placed in the appropriate tissue context.
Subcutaneous xenotransplantation into immunocompro-
mised mice represents the most widely used method for the
analysis of human melanoma formation (Khavari, 2006;
Becker et al., 2010). Therefore, we compared the histology of
the reconstituted tumor (Figure 4b) with a matched sub-
cutaneous xenograft (Figure 4c), revealing an advantageous
effect of the humanized environment on tumor growth.
Whereas the humanized model system (Figure 4b) allowed
the generation of large, non-necrotic lesions closely resem-
bling human melanoma histopathology (Figure 4a), subcuta-
neous inoculation resulted in highly necrotic tumors that
lacked any epidermal involvement (Figure 4c and Supple-
mentary Figure S3 online). Despite the abundant vasculariza-
tion (Supplementary Figure S3d online), higher magnification
revealed only a small rim of healthy (Figure 4c, inset 1),
proliferating (Supplementary Figure S3e online) cells on the
periphery of the tumor-facing necrotic areas inside the tumor
(inset 2). This suggests that additional influences from the
In vivo tumor progression
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Figure 3. Human melanoma induction and progression in engineered skin
substitutes in vivo. (a–c) Growth kinetics of green fluorescent protein (GFP)-
expressing human primary melanoma cells (ID12741) upon transplantation.
The left panels show the macroscopic maturation of the transplants,
whereas the middle and left panels show a magnified view of consecutive
hematoxylin and eosin (H/E)- and GFP-stained transversal sections
(e, epidermis; d, dermis). Bars¼ 100mm. (d and e) Histological comparison of
the reconstituted tumor (ID12741) and the corresponding primary patient
tumor (ID12741). Apart from the differences in size, both lesions show a
similar nodular growth pattern featuring lentiginous nests and epithelial
spread of single cells (insets 1), dermal invasion and ulceration (insets 2),
vascularization, and a similar overall cell morphology. Overview
bars¼ 1mm, inset bars¼ 100mm.
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microenvironment are required to sustain tumor growth and
progression independent of the vasculature. In addition, none
of the reconstituted tumors (N¼ 19 tumors derived from three
different patient samples), including their occasionally arising
dermal metastases, ever invaded the underlying rat tissue
(Figure 4b and Supplementary Figure S1 online, dotted lines).
Taken together, this indicates a favorable effect of the
engineered human stroma on human melanoma cell growth
and progression (Bhowmick et al., 2004; Ridky et al., 2010),
highlighting the paramount importance of a fully humanized
environment in studying melanoma progression.
Vascularization and hypoxia in reconstituted melanoma
A crucial step during tumor progression and a promising
target for drug development is neoangiogenesis. A key
parameter guiding this process is hypoxia resulting from the
imbalance of oxygen supply and consumption in a growing
tumor mass. (Pouysse´gur et al., 2006; Bedogni and Powell,
2009). To validate the potential use of reconstituted
melanoma in studying neoangiogenesis, we immunohisto-
chemically assessed vascularization and hypoxia in recon-
stituted skin and tumors. The dermal compartment of skin
substitutes transplanted without melanoma cells displayed
hypoxia and vascularization similar to the dermis of
normal skin (Figure 5a and b, arrowheads). In contrast, in
reconstituted melanoma samples, we observed a correlation
between pronounced hypoxia and tumor vessel ingrowth
(Figure 5c–e). GFP tracking of melanoma cells revealed that
tumor vessels were predominantly host derived (data not
shown), in agreement with the previous reports (Civenni
et al., 2011). Both, in an early-stage patient sample and the
reconstituted tumor after 25 days, blood vessel ingrowth was
found along highly hypoxic regions (Figure 5c and d,
arrowheads). This onset of hypoxia-guided blood vessel
ingrowth most likely set the basis for the subsequent rapid
progression to the highly vascularized, non-necrotic lesions
observed after 42 days in vivo (Figure 5e and f).
Reconstituting the switch from radial to vertical growth in
melanoma
As malignant disease remains the central challenge in
melanoma therapy, we further investigated the potential of
the system to faithfully recapitulate the early phases of human
tumor progression. The first step toward malignant disease is
the switch from radial to vertical tumor growth. Radial
growth is restricted to the epidermal compartment, whereas
vertical growth extends through the basement membrane into
the dermis. Thus, we analyzed the functional integrity of the
basement membrane in reconstituted tumors at different
progression stages (Figure 6a). Starting with an intact, fully
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Figure 4. Reconstitution of a primary melanoma from an axillary skin metastasis sample. (a) Patient-matched primary tumor (ID11928) that gave rise to
the metastasis used for reconstitution. (b) Tumor reconstituted from cells originally isolated from the corresponding axillary skin metastasis (ID4286). The
resulting tumors show identical growth characteristics as the original primary tumor (insets). Note the barrier presented by the distinct human–rat tissue border
(dotted lines) restricting tumor growth to the humanized dermal compartment. (c) Matched subcutaneous xenograft (ID4286) in a Swiss nude mouse.
Subcutaneous inoculation results in highly necrotic (inset 1), encapsulated tumors growing in the subdermal fat tissue without epithelial involvement (inset 2).
Dotted line, border between murine skin and subdermal fat tissue. Overview bars¼ 1mm, inset bars¼100 mm.
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functional basement membrane, initial radial growth pro-
gressively reduced the underlying basement membrane until
complete loss ensued.
A key event driving this malignant progression is thought
to be a process reminiscent of epithelial-to-mesenchymal
transition that is associated with the acquisition of an
invasive, mesenchymal phenotype in epithelial tumor cells
(Thiery, 2002). Although not an epithelial tumor, human
melanoma express E-cadherin (Hsu et al., 2000), the loss of
which has been functionally implicated in epithelial-to-
mesenchymal transition and tumor cell dissemination in
some tumor types (Thiery, 2002). This makes E-cadherin an
interesting candidate to investigate potential epithelial-to-
mesenchymal transition-like processes underlying melanoma
cell dissemination. Therefore, we compared the expression
pattern of E-cadherin on histological samples of primary
patient (N¼4) and reconstituted melanoma (N¼9 tumors
derived from three different patient samples; Figure 6b–g).
During the early stages of tumor development (radial growth
phase), neither of the primary human tumors analyzed nor
any of the reconstituted tumors showed an overt down-
regulation of E-cadherin, which was strongly expressed in
epidermal lesions extending from the epidermis (Figure 6b
and e). Strikingly, E-cadherin expression was even retained in
bigger lesions showing distinct vertical growth phase
characteristics (Figure 6c and f). In contrast, both in the
reconstituted tumors and in the patient samples, substantial
downregulation of E-cadherin was only observed in dermal
tumor cell infiltrates that had lost all contacts with the
epidermis (Figure 6d and g). In addition, in 12 out of 13
samples analyzed (N¼4 patient samples and nine recon-
stituted tumors), E-cadherin-negative cells were observed,
which appeared to move away from the parental tumor
(Figure 6b–g, arrowheads). Taken together, our data show that
even complex events such as dermal invasion, the induction
of neoangiogenesis, and early tumor cell dissemination were
faithfully recapitulated using our humanized melanoma
reconstitution approach.
DISCUSSION
Here we describe a fully humanized in vivo system faithfully
recapitulating all initial steps of human melanoma progres-
sion. In the same system, radial growth including pagetoid
spread, vertical growth, marker expression, angiogenesis,
ulceration, and hypoxia were validated in direct comparison
with patient-matched tumor samples. Interestingly, all these
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Figure 5. Vascularization and hypoxia in the reconstituted tumors. (a and b)
Immunohistochemical analysis of vascularization (CD31) and the hypoxia-
associated glucose transporter-1 (Glut) (arrowheads) in adjacent histological
sections of human skin and reconstituted (Reconst.) dermal epidermal skin
substitute. (c and d) Comparison of an early-stage patient sample (ID 16754)
and a reconstituted tumor (ID 4286) after 25 days indicates blood vessel
ingrowth along a highly hypoxic region (arrowheads). (e) After 42 days
in vivo, the reconst. tumors (ID 4286) are highly vascularized and contain
only a few small hypoxic regions. Bars¼ 100 mm. (f) Overview over hypoxia
and the intricate capillary network observed in the reconst. tumor after 42
days in vivo. Bars¼1mm.
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traits were reestablished upon tumor reconstitution with
samples derived from both primary melanomas and the
more abundant metastases biopsies. This demonstrates the
potential of cancer cells to adapt to the local environment,
making our system amenable to a wide range of human
melanoma samples. This concurs with recently described
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Figure 6. Reconstituting the switch from radial to vertical growth in melanoma. (a) Staining for the basement membrane marker Laminin-5 (Lam5) reveals
successive degradation of the basement membrane in a reconstituted melanoma (ID12741). The final loss of the basement membrane marks the onset of
vertical tumor growth. Bars¼ 100mm. (b–g) Comparison of E-cadherin (E-cad) expression in progressing stages of human primary (b–d) and reconstituted
melanoma (e–g). (b) Radially growing human primary tumor (ID12826). (c, d) Vertically growing human primary tumor (ID16754) with and without dermal
infiltrates (DIs). (e–g) Corresponding stages of a reconstituted tumor using human primary melanoma cells (ID12741). Arrowheads indicate cells negative
for E-cadherin without contact with their parental tumors. To visualize the tumor borders, the patient samples were counterstained with S100 and the
reconstituted tumors with green fluorescent protein (GFP). RGP, radial growth phase; VGP, vertical growth phase. Bars¼ 100 mm.
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dynamic processes mediating tumor initiation and mainte-
nance (Mani et al., 2008; Roesch et al., 2010). Along this
line, it will be interesting to assess how environmental cues
override the intrinsic differences between primary and
metastatic tumor cells.
A crucial point to consider for every model system is its
efficiency and reproducibility. Achieving an overall recon-
stitution efficiency of about 90% (17 tumors out of 19
transplantations using three individual patient samples), the
method described here provides a reliable and repeatable
experimental setup. Importantly, irrespective of the cells’
origin or previous expansion in vivo or in vitro, the different
samples did not exhibit any discernible differences with
respect to the key events of disease progression. This makes
our model a valuable tool for preclinical drug testing in an
experimental setup reminiscent of the patient’s situation. For
in vitro tumor cell expansion, we have purposely used
melanoma sphere cultures rather than adherent cell cultures.
This is because such cultures contain higher numbers of
tumor-initiating cells than adherent cell cultures and are able
to establish a cellular heterogeneity closely resembling that of
patients’ tumors (Fang et al., 2005; Civenni et al., 2011;
Thurber et al., 2011). Because melanoma spheres can readily
be generated both from fresh tumor biopsy samples and cell
lines passaged as adherent cultures, this method is applicable
to a large variety of samples.
Most patients die of metastatic disease and not of primary
tumor growth (Nguyen and Massague´, 2007). Therefore, we
also assessed systemic metastatic spread upon transplanta-
tion by checking all animals for metastatic lesions in the
inguinal and axillary lymph nodes, lung, intestine, and liver.
Unfortunately, no macroscopic visceral metastases were
found in the range of this study. Considering that metastatic
disease is a rare event, which in humans can take decades to
evolve (Nguyen and Massague´, 2007), we did not expect to
find distant metastases already after 42 days in vivo.
However, whether single tumor cells are already present in
the internal organs at the time point analyzed could not
concludingly be determined and is subject to further
investigations.
In contrast to previously described model systems (Juhasz
et al., 1993; Chudnovsky et al., 2005; Boiko et al., 2010), we
use organotypic skin substitutes as the basis for an orthotopic
in vivo model. This approach offers the advantage to
reconstruct skin grafts from distinct cellular components,
allowing the engineering of a fully humanized organotypic
environment. Moreover, all cell types used for melanoma
reconstruction can be manipulated, including the melanoma
cells, the KCs, and the dermal fibroblasts. To our knowledge,
for the first time, this will allow in vivo studies addressing the
influence of a human microenvironment on tumor progres-
sion in a defined experimental setup. The significance of such
studies becomes apparent by our observation that the
humanized dermal compartment clearly exerted a favorable
effect on tumor growth as compared with the neighboring rat
tissue. Given the known influence of stromal fibroblast on
tumor growth and progression (Bhowmick et al., 2004;
Gaggioli et al., 2007; Ridky et al., 2010), the use of a fully
humanized dermal compartment containing human fibro-
blasts is therefore favorable over a chimeric dermal compart-
ment that results from the repopulation of devitalized human
dermal substrate with recipient animal fibroblasts (Medalie
et al., 1996; Chudnovsky et al., 2005; Khavari, 2006).
The influence of the microenvironment has to be
considered especially when studying tumorigenesis in sub-
cutaneous xenografts (Quintana et al., 2008, 2010; Schatton
et al., 2008). Subcutaneous injections are placed into the
subdermal compartment, which according to our findings
represents an unphysiological environment for tumor growth
and is associated with extensive necrosis in the transplanted
tumor tissue. Thus, recent controversial findings regarding the
nature of melanoma-initiating cells (Quintana et al., 2008,
2010; Schatton et al., 2008; Refaeli et al., 2009; Boiko et al.,
2010; Roesch et al., 2010) may indeed partly be attributed to
the use of subcutaneous xenografts in some of these studies
(Dirks, 2010). Moreover, apart from creating an unphysiolo-
gical environment, subcutaneous xenografts do not recapitu-
late the invasive behavior of melanoma (Khavari, 2006), and
thus should not be considered an orthotopic model system.
As a result, it has been suggested that studies performed with
human samples should be validated in a humanized in vivo
environment (Weinberg et al., 2010). A recent report has
used intradermal injections into human foreskin grafts (Boiko
et al., 2010). However, similar to subcutaneous injections,
intradermal inoculation cannot entirely reproduce the early
stages of tumor progression. This is because the initial
influence of the microenvironment and the crucial switch
from radial to vertical growth are sidestepped upon dermal
seeding of melanoma cells. Thus, even if applied to the
context of a human skin graft, intradermal injections also do
not represent a fully orthotopic model system.
Although our model closely mimics human disease
progression, the use of immunocompromised recipient
animals for transplantation creates the inherent problem of
an incomplete immune system. As the immune system is
considered to have an important impact on growth and
progression of tumors, including human melanoma (Kim
et al., 2006; McAllister and Weinberg, 2010; Schatton et al.,
2010; Civenni et al., 2011), this aspect falls short in every
model system using human cells. Indeed, only few host
macrophages and natural killer cells were found close to or
within the reconstituted human tumors in our model system
(data not shown). Despite this limitation, we feel that the use
of human patient samples remains crucial for the develop-
ment of therapeutics targeting human cancer cells. This is
particularly relevant given the significantly different archi-
tecture of human and rodent skin, with human melanocytes
mainly residing in the interfollicular epidermis and rodent
melanocytes being mostly confined to hair follicles (Khavari,
2006). Therefore, although crucial for the identification of
molecular processes involved in tumorigenesis, genetic
mouse melanoma models only approximate the human
disease (Becker et al., 2010), thus impeding their direct
translation to the clinic.
In contrast, the model system described here allows
the faithful recapitulation of the central steps of human
www.jidonline.org 151
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melanoma growth and progression in a physiological,
humanized environment in vivo. This in turn will help to
translate basic research into a clinically more relevant context
by providing the opportunity to devise and test therapeutics in
a model system closely resembling the human disease.
MATERIALS AND METHODS
Construction of the human organotypic skin cultures
This study was conducted according to the Declaration of Helsinki
Principles. Human foreskin samples were obtained from patients
after obtaining permission from the Ethics Commission of the Canton
Zurich and after informed consent given by parents or patients.
Organotypic cultures were prepared as previously established
(Costea et al., 2003; Pontiggia et al., 2009; Biedermann et al.,
2010). Corresponding to the physiological ratio of melanocytes to
KCs (B1:5), 5 104 melanocytes or melanoma cells were seeded
onto each dermal equivalent. Culturing for 1 week with regular
medium changes gave rise to the dermo–epidermal skin substitutes
used for transplantation. Detailed procedures are described in the
Supplementary information online.
Transplantation of the human organotypic skin substitutes
The study protocol was approved by the Local Committee for
Experimental Animal Research (permission number 135/2010). The
surgical procedure was performed as described previously (Pontiggia
et al., 2009; Schneider et al., 2009; Biedermann et al., 2010). Detailed
procedures are described in the Supplementary information online.
Tumor cell isolation and xenograft inoculation
All patients enrolled in the study were treated at the Dermatology
Department of the University Hospital of Zurich. The biobank
project including the establishment of cell cultures was approved by
the local IRB (EK647 and EK800; Ethics Committee of Canton Zurich)
and all patients gave written informed consent. The patient samples
used for transplantation were derived from one primary tumor and
two metastases (see Supplementary Table S1 online). Detailed
procedures are described in the Supplementary information online.
Cell culture and staining procedures
Detailed procedures are described in the Supplementary information
online.
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